This site is intended for healthcare professionals

CPD
CPD
Pro
Pro
Sign in
Go to /sign-in page

You can view 5 more pages before signing in

Go to /pro/cpd-dashboard page

This page is worth 0.05 CPD credits. CPD dashboard

Go to /account/subscription-details page

This page is worth 0.05 CPD credits. Upgrade to Pro

Cautions using fentanyl patches

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

  • fentanyl blood levels rise slowly - continue previous medication for 24 hours
  • fentanyl blood levels fall slowly on removal - there is prolonged toxicity in overdose
  • fentanyl has a long half-life - increase dose only every third day
  • ensure that analgesia for breakthrough pain is always available
  • avoid heat pads near a patch - these increase absorption and hence the risk of overdosage

Also use with caution:

  • if the patient has not had strong opioids
  • patients previously on doses of oral morphine (or equivalent opioid) < 60mg/24hr
  • pyrexial patients where rate of absorption may be unpredictable
  • with poor adherence of patches, e.g. patient with sweats or when applied to the chest wall of patients who are cachectic
  • during the dying phase - seek specialist palliative care advice

Contraindications: Sensitivity to fentanyl or silicone medical adhesive

Reference:

  • (1) West Midlands Palliative Care Physicians (2012). Palliative care - guidelines for the use of drugs in symptom control.

Create an account to add page annotations

Create a free account

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.